Incentives and disincentives for new anti-tuberculosis drug development: situational analysis

http://whqlibdoc.who.int/HQ/2000/TDR_PRD_TB_00.1.pdf

This report, compiled through a series of interviews with staff of pharmaceutical companies, looks at the reasons for the lack of interest in TB drugs by the pharmaceutical industry, and at how to stimulate the development of anti-tuberculosis drugs. Document in pdf format; Acrobat Reader needed.

Author(s): Blanc, Diana Chang, Nunn, Paul Originator(s): World Health Organization - WHO
Resource added in: 16/02/2001
Available languages: English
Antitubercular Agents/economics, Drug Industry/economics
  • Share
  • Suggest tag
    [X]
    Suggestions
    Separated by comma
    [X]
    Thank you for your suggestion.
    Communication problem. Please try again later.
  • Report error
    [X]
    Reason
    New Link (Optional)
    [X]
    Thank you for your report.
    Communication problem. Please try again later.
comments powered by Disqus

More related